Skip to main content


Sanford Health selects national genomic oncology advisor

Mar 31, 2014 06:39PM ● By MED Magazine
A leading medical oncologist and geneticist at Stanford University has joined the Edith Sanford Breast Cancer team as its national genomic oncology advisor. James Ford, MD, will guide the organization on clinical research and personalized treatments for breast cancer.

As Edith Sanford’s national genomic oncology advisor, Dr. Ford will help develop and launch clinical trials in genomics and provide technical expertise to treating physicians based on the interpretation of genomic data gathered from those clinical trials.

“Dr. Ford is devoted to studying the genetic basis of breast cancer development, treatment and prevention,” said Gene Hoyme, MD, president of Sanford Research and chief academic officer. “His research vision supports that of Edith Sanford, which is to understand the role of genetic variances in cancer genes in regard to the risk and development of breast cancer and other common cancers.”

Dr. Ford is currently an associate professor of medicine (oncology) and genetics and director of the Stanford Cancer Genetics Clinic and the Cancer Genomics Program at Stanford University Medical Center. He graduated from Yale University in 1984 and received his medical degree from the Yale School of Medicine in 1989.

The recipient of numerous national awards, Dr. Ford is also an editor for Cancer Research, PLoS Genetics and DNA Repair and serves on the scientific review committee for the V Foundation for Cancer Research.

About Sanford Health and Edith Sanford Breast Cancer
Sanford Health is the largest rural nonprofit health care system in the nation with locations in 126 communities, in nine states. In addition, this dynamic integrated health system is now developing international clinics in Ghana, Israel and Mexico. Sanford Health has more than 26,000 employees, and includes 39 hospitals, 140 clinic locations and 1,360 physicians in 81 specialty areas of medicine.

In 2011, Sanford Health announced the launch of the Edith Sanford Breast Cancer initiative, a bold new endeavor to end breast cancer, comprised of state-of-the-art patient care, genomic research and national fundraising through the Edith Sanford Breast Cancer Foundation. For more information, visit or